ArticleBMC nephrology2026
Nephrologist-led fluoroscopic PD catheter insertion enables safe urgent-start PD: five-year single-center experience.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTimely placement of a functional peritoneal dialysis (PD) catheter is critical for PD utilization, particularly for patients requiring urgent dialysis initiation. Nephrologist-led percutaneous catheter insertion has been proposed as a streamlined alternative to surgical placement, but outcome data remain limited in some settings.
methodsWe conducted a retrospective review of all fluoroscopy-guided percutaneous PD catheter insertions performed by an interventional nephrology service at a tertiary center between 2019 and 2023. Outcomes included successful PD initiation, feasibility of urgent-start PD, and early complications within 30 days, including bleeding, mechanical dysfunction, infection, dialysate leak, and visceral injury. Complication rates were contextualized against published benchmarks.
resultsA total of 253 catheter insertions were performed in 243 patients (mean age 60.9 years; 56.8% male). PD was successfully initiated in 243 (96.0%) cases. Urgent-start PD was implemented in 75 (29.6%) cases, with a median initiation time of 1 day, whereas elective PD started on day 19. Clinically significant bleeding occurred in 28 (11.1%) cases, with major bleeding requiring transfusion or intervention in eight (3%) patients, occurring more frequently among urgent-start patients. Early mechanical dysfunction occurred in 10 (4.0%) cases. No early exit-site infections, peritonitis, dialysate leaks, or visceral injuries were observed within 30 days. Notably, the cohort included six successful procedures on patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), a group traditionally considered technically challenging for PD access.
conclusionsA nephrologist-led, fluoroscopy-guided percutaneous PD catheter insertion program enabled timely PD initiation, including urgent-start PD, with high procedural success and low rates of serious early complications. These findings support the safety and effectiveness of nephrologist-performed PD catheter insertion within a structured interventional nephrology service.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.